Global Artificial Saliva Market, By Product (Oral Spray, Oral Solution, Oral Liquid, Dissolving Tablets, Gel, Powder), End-Users (Adult, Paediatric), Distributional Channel (Supermarkets and Hypermarkets, Others) – Industry Trends and Forecast to 2030.
Artificial Saliva Market Analysis and Size
According to WHO data, oral diseases are the fourth most expensive to treat in emerging and developed economies. Oral health maintenance costs are a major healthcare issue that directly impacts the artificial saliva market. Increases in disposable income and per capita spending because consumers primarily drive the artificial saliva market are expected to drive the artificial saliva market over the forecast period.
Data Bridge Market Research analyses that the artificial saliva market, which was USD 1.1 billion in 2022, is expected to reach USD 3.14 billion by 2030, at a CAGR of 14% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Artificial Saliva Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015 - 2020)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product (Oral Spray, Oral Solution, Oral Liquid, Dissolving Tablets, Gel, Powder), End- Users (Adult, Paediatric), Distributional Channel (Supermarkets and Hypermarkets, Others)
|
|
Countries Covered
|
U.S., Canada, and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of the Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Market Players Covered
|
Cipla Inc. (India), Mission Pharmacal Company (U.S.), Fresenius Kabi AG (Germany), Parnell Pharmaceuticals, Inc. (U.S.), Forward Science (U.S.), Laboratorios KIN S.A. (Spain), ICPA Health Products Ltd (India), NANOCHEMAZONE (U.K.), Lee BioSolutions (U.S.), Livealth (India), GSK Plc (U.K.), CCMed Group (U.K.), ENTOD INTERNATIONAL (India), Midatech Pharma Plc. (U.K.), Valeant Pharmaceuticals International, Inc. (Canada), Biocosmetics Laboratories S.L. (Spain), Perrigo Company plc. (Ireland)
|
|
Market Opportunities
|
|
Market Definition
Artificial saliva is a saliva substitute that moistens and lubricates the mouth while also forming a protective film to help reduce the risk of mechanical trauma caused by chronic dry mouth. It can relieve symptoms such as mouth dryness, stickiness, and bad breath. Artificial saliva solutions used to assess the electrochemical behaviour of materials in the oral cavity do not accurately model many clinical conditions, such as the presence of cellular elements, inflammatory activators, or high glucose environments (hyperglycemia).
Global Artificial Saliva Market Dynamics
Drivers
- Growing prevalence of dry mouth syndrome
The rising prevalence of xerostomia, or dry mouth syndrome, that causes decreased salivary flow and mucosal dryness, propels the artificial saliva industry forward. As the risk of dry mouth syndrome and dysphagia rises due to radiation therapy and chemotherapy, the product's demand is also increasing due to the growing number of cancer cases worldwide. The growing geriatric population increased awareness about the fewer complications associated with oral gels and liquids and rising expenditure on oral care products all contribute to this trend. These are certain factors that propel the growth of the market.
- Use of artificial saliva assists in the prevention of dysphagia
Several studies have shown that consuming artificial saliva products reduces dysphagia symptoms in cancer patients. An aging population in developed regions such as Europe, North America, and Japan presents a lucrative opportunity for the dysphagia supplements market. According to Eurostar statistics for January 2015, patients over 65 made up approximately one-fifth of the population, a more than a 2% increase from a decade earlier. This should be a dedication in disguise for the artificial saliva market.
Opportunities
- Rising incidence of cancer
Artificial saliva is used to treat dry mouth. The rising incidence of cancer, as well as the increased need for cancer treatments such as radiation or chemotherapy, is increasing the incidence of dry mouth. Furthermore, aging is a major contributor to the occurrence of dry mouth. The abovementioned factors are increasing its adoption and propelling the global artificial saliva market forward. Artificial saliva products, such as oral gels and liquids, are simple to apply. It is more convenient for patients to use for oral hygiene.
Restraints/Challenges
- Side effects associated will pose a problem
Numerous side-effects associated with artificial saliva will pose a challenge to the growth of the market. Side-effects such as altered speech, abnormal taste, digestive problems and difficulty in swallowing hamper the credibility of artificial saliva. This will in turn, narrow down the scope of growth.
This artificial saliva market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the artificial saliva market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Artificial Saliva Market Scope
The artificial saliva market is segmented on the basis of product, distributional channel and end users. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Oral Spray
- Oral Solution
- Oral Liquid
- Dissolving Tablets
- Gel, Powder
End-Users
- Adult
- Paediatric
Distributional Channel
- Supermarkets and Hypermarkets
- Others
Artificial Saliva Market Regional Analysis/Insights
The artificial saliva market is analysed and market size insights and trends are provided by country, product, distributional channel and end users as referenced above.
The countries covered in the artificial saliva market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the artificial saliva market because of the easy availability of artificial saliva products and the presence of a large patient population in the country; artificial saliva demand in the region is expected to increase.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 owing to the easy availability of artificial saliva products and the presence of a large patient population in the country, which is expected to enhance the artificial saliva demand in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The artificial saliva market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for artificial saliva market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the artificial saliva market. The data is available for historic period 2011-2021.
Competitive Landscape and Artificial Saliva Market Share Analysis
The artificial saliva market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to artificial saliva market.
Some of the major players operating in the artificial saliva market are:
- Cipla Inc. (India)
- Mission Pharmacal Company (U.S.)
- Fresenius Kabi AG (Germany)
- Parnell Pharmaceuticals, Inc. (U.S.)
- Forward Science (U.S.)
- Laboratorios KIN S.A. (Spain)
- ICPA Health Products Ltd (India)
- NANOCHEMAZONE (U.K.)
- Lee BioSolutions (U.S.)
- Livealth (India)
- GSK Plc (U.K.)
- CCMed Group (U.K.)
- ENTOD INTERNATIONAL (India)
- Midatech Pharma Plc. (U.K.)
- Valeant Pharmaceuticals International, Inc. (Canada)
- Biocosmetics Laboratories S.L. (Spain)
- Perrigo Company plc. (Ireland)
SKU-